Total Liabilities: The total value of all possible claims against the corporation.
AEON Biopharma, Inc. (AEON) had Total Liabilities of $25.38M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-11.79M |
|
-- |
|
-- |
|
$5.93M |
|
$-5.93M |
|
$-5.86M |
|
$-11.79M |
|
$-11.79M |
|
$-11.79M |
|
$-11.79M |
|
$-11.79M |
|
$-11.79M |
|
$-5.93M |
|
$-5.91M |
|
40.61M |
|
40.61M |
|
$-0.29 |
|
$-0.29 |
|
| Balance Sheet Financials | |
$6.62M |
|
$0.14M |
|
$2.00M |
|
$8.63M |
|
$6.67M |
|
$1.54M |
|
$18.71M |
|
|
Total Liabilities |
$25.38M |
$-16.75M |
|
$-16.75M |
|
$-16.75M |
|
25.30M |
|
| Cash Flow Statement Financials | |
$-2.64M |
|
$0.00M |
|
$5.87M |
|
$3.01M |
|
$6.24M |
|
$3.24M |
|
$1.93M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.99 |
|
-- |
|
-- |
|
-0.10 |
|
-0.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
70.40% |
|
70.40% |
|
-136.65% |
|
77.53% |
|
$-0.66 |
|
$-0.06 |
|
$-0.06 |
|